Serving Size: 3 Capsules... %DV
Magnesium (from magnesium bisglycinate)... 100 mg 25%
Longvida® Optimized Curcumin* (from Curcuma longa root 25-30:1 ) 40 mg†
California Poppy extract (Eschscholzia californica 10:1)... 20 mg†
L-Carnitine (from L-carnitine tartrate)... 680 mg †
Ginger extract (Zingiber officinale 10:1)... 100 mg †
†Daily Value not established
What Is It?
Fem Ease is formulated with several natural ingredients that, when taken several days before and during menstruation, help relieve the physical symptoms of premenstrual syndrome (PMS) and dysmenorrhea.
What Does It Do?Primary Uses: The ingredients in Fem Ease help relieve the debilitating pain and cramping of dysmenorrhea. L-Carnitine helps reduce muscle cramping and supports muscle recovery. Ginger reduces muscle pain and cramping related to menstruation, and has even been shown to be as effective as NSAIDs. Curcumin has been shown to reduce pain and inflammation related to menstruation. Magnesium helps relax the muscles. Magnesium and California poppy provide mood support and relaxation effects, which is important since moodiness and higher stress have been linked to greater menstrual pain. Secondary Uses: Fem Ease can also be used by both men and women to relax muscles and relieve general muscle pain, for example, after a workout.
Who Should Take It?
Women who suffer from physical symptoms of PMS like cramping and back pain should take Fem Ease. For mood support related to PMS, Fem Ease is best used with Fem Calm. Fem Ease can also benefit athletes and those who experience frequent muscle tension and discomfort for various reasons.
For menstrual discomfort take 3 capsules two to three times daily, 2 days prior to menstruation until 3 days afterward. To help relieve other symptoms, take 3 capsules one to three times daily. Take with food and as directed by a qualified health care practitioner.
Abass, M. 2012. Evaluation of Serum Magnesium , Hemoglobin and Body Mass Index in Dysmenorrheic Women in Tikrit Ciy/Iraq, Tikrit. Journal of Pure Science; 17(4): 59-62.
Allais G, Bussone G, De Lorenzo C, Mana O, Benedetto C. Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurol Sci. 2005 May;26 Suppl 2:s125-9.
Berna, C., Leknes, S., Holmes, E., Edwards, R., Goodwin, G., & Tracey, I. 2010. Induction of Depressed Mood Disrupts Emotion Regulation Neurocircuitry and Enhances Pain Unpleasantness. Biological Psychiatry; 67(11): 1083-90.
Bettendorf B, Shay S, Tu F. Dysmenorrhea: contemporary perspectives. Obstet Gynecol Surv. 2008 Sep;63(9):597-603.
Chan, W. & Hill, J. 1978. Determination of Menstrual Prostaglandin Levels in Non-dysmenorrheic and Dysmenorrheic Subjects. Prostaglandins; 15(2): 365-375.
Dawood, M. 1986. Current Concepts in the Etiology and Treatment of Primary Dysmenorrhea. Acta Obstet Gynecol Scand Suppl; 138: 7–10.
Facchinetti, F., Borella, P., Sances, G., Fioroni, L., Nappi, R. , & Genazzani, A. 1991. Oral Magnesium Successfully Relieves Premenstrual Mood Changes. Obstetrics & Gynecology; 78(2): 177.
Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991). Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31:298–301
Fontana-Klaiber H, Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax. 1990 Apr 17;79(16):491-4.
Gafner, S., Dietz, B., McPhail, K., Scott, I., Glinski, J., Russell, F., McCollom, M., Budzinski, J., Foster, B., Bergeron, C., Rhyu, M., & Bolton, J. 2006. Alkaloids from Eschscholzia californica and Their Capacity to Inhibit Binding of [3H]8-Hydroxy-2-(di-N-propylamino)tetralin to 5-HT1A Receptors in vitro. J Nat rod.; 69(3): 432-435.
Ghayur, M. & Gilani, A. 2007. Inhibitory Activity of Ginger Rhizome on Airway and Uterine Smooth Muscle Preparations. European Food Research and Technology; 224(4): 477-481.
Gollenberg, A., Hediger, M., Mumford, S., Whitcomb, B., Hovey, K., Wactawski-Wende, J., & Schisterman, E. 2010. Perceived Stress and Severity of Perimenstrual Symptoms: The BioCycle Study. Journal of Women's Health; 19(5): 959-967.
Gulcin I. 2006. Antioxidant and Antiradical Activities of L-Carnitine. Life Science; 78: 803-811.
Jenabi, E. 2013. The effect of Ginger for Relieving of Primary Dysmenorrhoea. J Pak Med Assoc.; 63(1): 8-10.
Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2014;36(1):104-13.
Kiuchi, F., Iwakami, S., Shibuya, M., Hanaoka, F., & Sankawa, U. 1992. Inhibition of Prostaglandin and Leukotriene Biosynthesis by Gingerols and Diarlherptanoids, Chem Pharm Bull.; 40(2): 387-391.
Ko, Y. , Hong, S., & Pedersen, P. 1999. Chemical Mechanism of ATP Synthase. Magnesium Plays a Pivotal Role in Formation of the Transition State Where ATP is Synthesized from ADP and Inorganic Phosphate. Journal of Biological Chemistry; 274(41): 28853-28856.
Kumar A, Purwar B, Shrivastava A, Pandey S. Effects of curcumin on the intestinal motility of albino rats. Indian J Physiol Pharmacol. 2010 Jul-Sep;54(3):284-8.
Ozgoli, G., Marjan, G., & Fariborz M. 2009. Comparison of Effects of Ginger, Mefenamic Acid, and Ibuprofen on Pain in Women with Primary Dysmenorrhea. The Journal of Alternative and Complementary Medicine; 15(2): 129-132.
Pharmacopoeia of the People's Republic of China, 2005, Part I, Volume I, page 121.
RaO, S., & Vijyasree, M. 2011. Oxidative Stress and Antioxidant Status in Primary Dysmenorrhea. Journal of Clinical and Diagnostic Research; 5: 509-511.
Rahnama, P., Montazeri, A., Huseini, H., Kianbakht, S. & Naseri, M. 2012. Effect of Zingiber officinale R. Rhizomes (Ginger) on Pain Relief in Primary Dysmenorrhea: A Placebo Randomized Trial. BMC Complementary and Alternative Medicine; 12:92.
Rupa Vani K, Veena KS, Subitha L, Hemanth Kumar VR, Bupathy A. Menstrual abnormalities in school going girls – are they related to dietary and exercise pattern? J Clin Diagn Res. 2013 Nov;7(11):2537-40.
Sakurauchi, Y., Matsumoto, Y., Shinzato, T., Takai, I., Nakamura, Y., Sato, M., & Maeda, K. 1998. Effects of L-Carnitine Supplementation on Muscular Symptoms in Hemodialyzed Patients. American Journal of Kidney Diseases; 32(2): 258-264.
Spiering, B., Kraemer, W., Vingren, J., Hatfield D., Fragala M., Ho J., Maresh C., Anderson J., & Volek, J. 2007. Responses of Criterion Variables to Different Supplemental Doses of L-Carnitine L-Tartrate. The Journal of Strength & Conditioning Research; 21(1): 259-264.
Stults-Kolehmainen, M., & Bartholomew, J. 2012. Psychological Stress Impairs Short-Term Muscular Recovery from Resistance Exercise. Medicine & Science in Sports & Exercise; 44(11): 2220-2227.
Wall, B., Stephens, F., Constantin-Teodosiu, D., Marimuthu, K., Macdonald, A. & Greenhaff, P. 2011.
Yanagida, T., Arata, T., & Oosawa, F. 1985. Sliding distance of actin filament induced by a myosin crossbridge during one ATP hydrolysis cycle. Nature; 316 (6026):366-369.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.